Disability in pediatric inflammatory bowel diseases: A systematic review and a single center experience.

Authors

Reut Rappaport, Ouriel Hannaux, Gili Focht, Liron Marcovitch, Elana Gotkine, Ohad Atia, Esther Orlanski-Meyer, Raffi Lev-Tzion, Oren Ledder, Dotan Yogev, Eileen Crowley, Anthony Otley, Anne M Griffiths, Dan Turner

Published in

Journal of pediatric gastroenterology and nutrition. Sep 22, 2026. Epub Sep 22, 2026.

Abstract

Toward development of a pediatric IBD disability index (PIDI), we aimed to review the literature on disability in pediatric inflammatory bowel disease (PIBD) and to estimate disability rates in a pediatric inception cohort.
A systematic review identified studies reporting disability in PIBD and in adult randomized controlled trials (RCTs) with disability as the primary outcome. In parallel, seven disability-related IMPACT-III items were retrieved at 4 and 12 months after diagnosis from a prospectively followed inception cohort of PIBD. Items were scored 0-100 (≤75 mild, ≤50 moderate, and ≤25 severe disability), supported by a validation sub-study.
Thirteen pediatric studies were included of which 10 used the functional disability inventory, a generic disability tool not developed for PIBD. Any disability was found in 55% and 100% in the two studies that reported rates. Three adult RCTs used generic patient-reported measures of participation in daily activities and showed modest, inconsistent improvement in disability with heterogenous interventions. The inception cohort included 80 children, of whom 38% had any disability at 4 months and 10% had moderate-severe disability. These rates declined to 18% and 0% at 12 months, respectively. Dietary restrictions, sports participation, travel, and school functioning were the most affected domains. At 4-months, any degree of disability was higher in those with active disease (61%) versus inactive disease (17%, p < 0.001).
Disability literature in PIBD is scarce and lacks a pediatric-specific instrument. Functional limitations were frequent and persisted in some children despite reaching clinical remission. These findings underscore the need for standardized disability assessment in PIBD.

PMID:
42768931
Bibliographic data and abstract were imported from PubMed on 22 Sep 2026.

Read full publication at:
Please sign in to see all details.

Stats

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.